BioDelivery Sciences International, Inc (BDSI)

Etorro trading 970x250
BioDelivery Sciences International, Inc (BDSI) Logo

About BioDelivery Sciences International, Inc

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina. Address: 4131 ParkLake Avenue, Raleigh, NC, United States, 27612

BioDelivery Sciences International, Inc News and around…

Latest news about BioDelivery Sciences International, Inc (BDSI) common stock and company :

BioDelivery Sciences to Report Third Quarter 2021 Financial Results on November 3, 2021
20 Oct, 2021 Yahoo! Finance

RALEIGH, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced today that it will report its third quarter 2021 financial results before the open of the U.S. financial markets on Wednesday, November 3, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operation

SMLV's Underlying Holdings Imply 10% Gain Potential
07 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— SSGA US Small Cap Low Volatility Index ETF (SMLV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $125.23 per unit.

Here's Why We Think BioDelivery Sciences International (NASDAQ:BDSI) Is Well Worth Watching
03 Oct, 2021 Yahoo! Finance

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

BioDelivery Sciences International to Host ELYXYB™ Investor Day
30 Sep, 2021 FinancialContent
Noteworthy Friday Option Activity: BDSI, SHAK, SPR
24 Sep, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioDelivery Sciences International Inc (BDSI), where a total of 7,805 contracts have traded so far, representing approximately 780,500 underlying shares. That amounts to about 73.6% of BDSI's average daily trading volume over the past month of 1.1 million shares..

50 Biggest Movers From Yesterday
23 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement ...

32 Stocks Moving In Wednesday's Mid-Day Session
22 Sep, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that ...

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
22 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

BioDelivery Sciences International (BDSI) is a Top-Ranked Momentum Stock: Should You Buy?
21 Sep, 2021 Yahoo! Finance

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Top Pharmaceutical Stocks for Q4 2021
14 Sep, 2021 Yahoo! Finance

These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q4 2021.

4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%
14 Sep, 2021 FinancialContent
Best Reddit Penny Stocks To Buy Now? 5 For Your List In September 2021
12 Sep, 2021 FinancialContent
BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada
09 Sep, 2021 FinancialContent
BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference
07 Sep, 2021 FinancialContent
BioDelivery (BDSI) Up 3.2% Since Last Earnings Report: Can It Continue?
03 Sep, 2021 Yahoo! Finance

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences
03 Sep, 2021 FinancialContent
Market Cool On BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) Earnings
03 Sep, 2021 Yahoo! Finance

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 18x, you may...

Top Penny Stocks You Need to Know About Right Now
20 Aug, 2021 FinancialContent
Notable Tuesday Option Activity: BDSI, BLK, AAWW
17 Aug, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioDelivery Sciences International Inc (BDSI), where a total of 5,420 contracts have traded so far, representing approximately 542,000 underlying shares. That amounts to about 113.1% of BDSI's average daily trading volume over the past month of 479,350 shares..

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors
16 Aug, 2021 FinancialContent

AzurRx expands Board of Directors to seven members with new appointment

Analysts Expect ESML Will Reach $46
05 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares ESG Aware MSCI USA Small-Cap ETF (ESML), we found that the implied analyst target price for the ETF based upon its underlying holdings is $45.76 per unit.

BioDelivery Sciences International, inc (BDSI) Q2 2021 Earnings Call Transcript
04 Aug, 2021 FinancialContent

BDSI earnings call for the period ending June 30, 2021.

BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range
04 Aug, 2021 FinancialContent

BioDelivery Sciences International Inc(NASDAQ: BDSI) hasreported Q2 sales of $41.4 million, + 13.3% Y/Y, missing the ...

10 Pharma Companies Making Treatment for Opioid Overdose
04 Aug, 2021 Yahoo! Finance

In this article, we discuss the 10 pharma companies making treatment for opioid overdose. If you want to skip our detailed analysis of these stocks, go directly to the 5 Pharma Companies Making Treatment for Opioid Overdose. On July 21, a group of four state attorneys general in the United States announced that they had […]

BioDelivery Sciences International (BDSI) Beats Q2 Earnings Estimates
04 Aug, 2021 Yahoo! Finance

BioDelivery (BDSI) delivered earnings and revenue surprises of 80.00% and -1.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

BioDelivery Sciences Reports Second Quarter 2021 Results
04 Aug, 2021 FinancialContent
BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the Acute Treatment of Migraine
04 Aug, 2021 FinancialContent
Update: BioDelivery Sciences International (NASDAQ:BDSI) Stock Gained 56% In The Last Five Years
04 Aug, 2021 Yahoo! Finance

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...

BioDelivery Sciences International (BDSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
28 Jul, 2021 Yahoo! Finance

BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BioDelivery Sciences to Report Second Quarter 2021 Financial Results on August 4, 2021
22 Jul, 2021 FinancialContent

BioDelivery Sciences International, Inc (BDSI) is a NASDAQ Common Stock listed in , ,

970x250